Canakinumab Subcutaneous and Dilacor XR
Determining the interaction of Canakinumab Subcutaneous and Dilacor XR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: diltiazem
Brand name: Cardizem, Cartia XT, Dilacor XR, Dilt-CD, Diltia XT, Diltzac, Matzim LA, Taztia XT, Tiazac, Cardizem CD, Dilt-XR, Tiazac, Cardizem LA, Tiazac Extended Release Capsules
Synonyms: Dilacor XR (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Dilantin
- Canakinumab Subcutaneous-Dilantin Infatabs
- Canakinumab Subcutaneous-Dilantin injection
- Canakinumab Subcutaneous-Dilantin Kapseals
- Canakinumab Subcutaneous-Dilantin-125
- Canakinumab Subcutaneous-Dilantin-30
- Dilacor XR-Canasa
- Dilacor XR-Canasa Pac rectal
- Dilacor XR-Canasa rectal
- Dilacor XR-Cancidas
- Dilacor XR-Candesartan
- Dilacor XR-Candesartan and Hydrochlorothiazide